Course Description
The future of clinical dentistry is evolving rapidly. Cutting and fabrication with mechanical tools is being rapidly replaced with laser technology. The precision and control with a laser are unmatched and technological advancements have made these clinical viable as evident by the recent ADA recognition. Besides the surgical applications, light-based therapies like photodynamic therapy and photobiomodulation offer new avenues to elevate clinical care. This program will provide a fundamental overview of clinical laser technology, safety requirements, and the biological rationale for various clinical applications. The hands-on exercises for the surgical and PBM applications will emphasize the dosing and clinical delivery aspects to provide a foundational introduction to more advanced, procedure-specific future training.
-
- To outline the fundamentals of laser technology and clinical safety
- To elaborate on the biological rationale for surgical and non-surgical laser clinical applications
- To emphasize the novel clinical dosing and delivery for each approach
-
Please arrive within 30 minutes before the course start time to sign in.
-
Complimentary lunch is provided for course participants. Please indicate any dietary restrictions upon registration.
Hands-on materials and equipment are provided for participants to use in the course.
-
Cancellations made more than 10 calendar days before the course start date will receive a full refund. No refunds will be issued for cancellations made within 10 calendar days of the course start date.
Refunds will not be issued for registrants who do not attend, regardless of reason for absence.
Registrations cannot be transferred to another individual.
To cancel your registration, please follow the link and instructions provided in the registration confirmation email. If you are eligible for a refund, the refund will be processed automatically upon cancellation. Please allow 3-5 business days for the transaction to be completed.
Continuing Dental Education (University of Toronto) reserves the right to cancel courses due to insufficient registrations, instructor cancellation, or unforeseen circumstances beyond our control. In the event of course cancellation, a full refund will be issued, and registrants will be notified promptly. We are not liable for any associated losses, damages, or expenses, including travel and accommodations.
-
After completing this course, a certificate of completion that indicates the number of Continuing Education (CE) points earned will be sent to you within 7-10 days by email.
Instructor
Dr. Praveen Arany is trained as a dentist, oral pathologist, and biomedical engineer. He served as an Assistant Clinical Investigator at NIDCR/NIH, Bethesda and is currently an Associate Professor, with tenure at the University at Buffalo, NY. He has 6 patents, over 150 scientific publications with over 10600 citations with an of 41. His research has been featured in many mainstream media highlights in over 70 countries. He has received numerous awards recognizing his research contributions such as Excellence in Photobiomodulation Research award (WALT) and Theodore Maiman Award (Academy of Laser Dentistry). He speaks in various national and international forums, serves as a reviewer for a broad range of scientific journals including several editorial boards and national and international funding agencies. He is the current chair of the PBM group in Optica (OSA), past president of World and North American Association for Photobiomodulation Therapy, and Lasers Biophotonics Group, International Association of Dental Research.
Dr. Arany has been a key figure in organizing the field of Photobiomodulation. As an intramural investigator at NIDCR/NIH and leadership positions in WALT and NAALT, he was instrumental in adoption of the nomenclature for Photobiomodulation (PBM) as a MeSH term for Pubmed over 300 other terms such as cold laser treatments or low-level light/laser therapy. His research has demonstrated a novel PBM molecular mechanism involving latent TGF-beta 1 activation that drives tissue resilience, regeneration, and immunomodulation that is finding a broad range of clinical applications from burn wounds to dentin repair. His lab has outlined key clinical biomarkers (tissue surface temperature), molecular biomarkers (ATF-4), treatment delivery (target surface irradiance), and dosimetry (Photonic fluence and Einstein) that is enabling safe and effective PBM clinical protocols. These advances have contributed to clinical practice guidelines recommendations for treating several human diseases and promoting wellness, especially in supportive cancer care. Among his major contributions, he led the ADA technical bulletin recognizing PBM in clinical dentistry.